CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity, Reactogenicity and Safety Study of Pediarix®, Hiberix® and Prevenar 13® Co-administered With Two Different Formulations of GSK Biologicals' HRV Vaccine (444563) in Healthy Infants 6-12 Weeks of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03207750
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:53.160189+00:00
Published At: 2019-10-31T00:00:00+00:00
Record Updated At: 2020-12-29
Results Posted At: 2019-10-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rotavirus Infection", "Rotavirus Vaccines"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-12-29"
protocolSection.identificationModule.nctId: "NCT03207750"
protocolSection.identificationModule.officialTitle: "Immunogenicity, Reactogenicity and Safety Study of Pediarix\u00ae, Hiberix\u00ae and Prevenar 13\u00ae Co-administered With Two Different Formulations of GSK Biologicals\u0027 HRV Vaccine (444563) in Healthy Infants 6-12 Weeks of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-10-31"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.